[4] The interest in GHK-Cu subcutaneous and systemic delivery grows directly out of that origin story: because GHK is an endogenous plasma peptide that the body already produces and distributes through the circulation, researchers have long asked what happens when additional GHK-Cu is introduced into the systemic compartment rather than confined to a single local site
Similarly, NAD + levels appear reduced in preclinical models of age-associated diseases, including ataxia-telangiectasia (A-T), mitochondrial myopathies, and Alzheimers disease (AD), and disease-matched clinical samples 114,242,243,244,245,246
By incorporating a precise ratio of four extensively researched peptides into a single lyophilised vial, this complex allows investigators to observe a broad spectrum of cellular events simultaneously
Generally, individuals with lighter complexions may see results in 1 to 3 months, while those with deeper skin tones may need 6 to 12 months of consistent use